Nasdaq or NYSE related Health Care sector Top Companies List by Market Cap as of August 2026
Nasdaq or NYSE listed Health Care sector Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Health Care sector Largest Companies List by Market Cap as of August 2026
-
World Rank (Aug-2026)5,787Market Cap (Aug-2026)2.354 Billion USDWorld Rank (Jan-05-2024)17,614Market Cap (Jan-05-2024)0.211 Billion USDWorld Rank (Jul-30-2023)12,915Market Cap (Jul-30-2023)0.487 Billion USDWorld Rank (Dec-25-2022)12,766Market Cap (Dec-25-2022)0.473 Billion USDWorld Rank (Jan-07-2022)8,478Market Cap (Jan-07-2022)1.20 Billion USDAnnual Revenue in USD98 Million USDAnnual Net Income in USD-77 Million USDAnnual Results for Period EndingFor year ending December-2025Company Website
-
CareDx Inc.
World Rank (Aug-2026)5,798Market Cap (Aug-2026)2.345 Billion USDWorld Rank (Jan-05-2024)11,463Market Cap (Jan-05-2024)0.602 Billion USDWorld Rank (Jul-30-2023)11,590Market Cap (Jul-30-2023)0.600 Billion USDWorld Rank (Dec-25-2022)11,241Market Cap (Dec-25-2022)0.603 Billion USDWorld Rank (Jan-07-2022)6,174Market Cap (Jan-07-2022)2.06 Billion USDAnnual Revenue in USD380 Million USDAnnual Net Income in USD-21 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileCaredx is a partner for transplant patients and the Transplant Ecosystem. The company products are Kidney Transplant, Heart Transplant, Lab Products, Digital and Remotrac. The headquarters is in USA.Company Website -
Dentsply Sirona
World Rank (Aug-2026)5,844Market Cap (Aug-2026)2.311 Billion USDWorld Rank (Jan-05-2024)2,103Market Cap (Jan-05-2024)7.559 Billion USDWorld Rank (Jul-30-2023)1,882Market Cap (Jul-30-2023)8.718 Billion USDWorld Rank (Dec-25-2022)2,079Market Cap (Dec-25-2022)6.841 Billion USDWorld Rank (Jan-07-2022)1,590Market Cap (Jan-07-2022)12.33 Billion USDAnnual Revenue in USD3,680 Million USDAnnual Net Income in USD-598 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileDENTSPLY SIRONA manufactures Medical devices related to dental equipment. Headquarters is in Pennsylvania, USA.
Company WebsiteWikipedia -
Vera Therapeutics Inc.
World Rank (Aug-2026)5,905Market Cap (Aug-2026)2.279 Billion USDWorld Rank (Jan-05-2024)10,674Market Cap (Jan-05-2024)0.689 Billion USDWorld Rank (Jul-30-2023)10,207Market Cap (Jul-30-2023)0.761 Billion USDWorld Rank (Dec-25-2022)11,799Market Cap (Dec-25-2022)0.550 Billion USDWorld Rank (Jan-07-2022)14,196Market Cap (Jan-07-2022)0.45 Billion USDAnnual Net Income in USD-300 Million USDAnnual Results for Period EndingFor year ending December-2025Company Website -
Mineralys Therapeutics Inc.
World Rank (Aug-2026)5,921Market Cap (Aug-2026)2.267 Billion USDWorld Rank (Jan-05-2024)14,697Market Cap (Jan-05-2024)0.355 Billion USDWorld Rank (Jul-30-2023)14,411Market Cap (Jul-30-2023)0.382 Billion USDAnnual Net Income in USD-155 Million USDAnnual Results for Period EndingFor year ending December-2025Company Website -
Vericel Corporation
World Rank (Aug-2026)5,928Market Cap (Aug-2026)2.263 Billion USDWorld Rank (Jan-05-2024)6,459Market Cap (Jan-05-2024)1.623 Billion USDWorld Rank (Jul-30-2023)6,143Market Cap (Jul-30-2023)1.797 Billion USDWorld Rank (Dec-25-2022)7,816Market Cap (Dec-25-2022)1.125 Billion USDWorld Rank (Jan-07-2022)6,909Market Cap (Jan-07-2022)1.71 Billion USDAnnual Revenue in USD276 Million USDAnnual Net Income in USD17 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileBio pharmaceutical company with headquarters is in USA.Company Website -
Atricure
World Rank (Aug-2026)5,942Market Cap (Aug-2026)2.253 Billion USDWorld Rank (Jan-05-2024)6,527Market Cap (Jan-05-2024)1.597 Billion USDWorld Rank (Jul-30-2023)4,782Market Cap (Jul-30-2023)2.615 Billion USDWorld Rank (Dec-25-2022)5,394Market Cap (Dec-25-2022)2.032 Billion USDWorld Rank (Jan-07-2022)5,055Market Cap (Jan-07-2022)2.83 Billion USDAnnual Revenue in USD535 Million USDAnnual Net Income in USD-11 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileAtriCure Provides Innovative Atrial Fibrillation Solutions company and related conditions, electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best in class solutions that can treat even the most complex cases. It served over 3,50,000 patients with ablation, over 2,500 healthcare professionals trained, products sold in over 50 countries and more than 700 employees worldwide. The headquarters is in USA.Company Website -
Harmony Biosciences Holdings Inc.
World Rank (Aug-2026)5,989Market Cap (Aug-2026)2.220 Billion USDWorld Rank (Jan-05-2024)5,928Market Cap (Jan-05-2024)1.871 Billion USDWorld Rank (Jul-30-2023)5,534Market Cap (Jul-30-2023)2.111 Billion USDWorld Rank (Dec-25-2022)3,759Market Cap (Dec-25-2022)3.363 Billion USDWorld Rank (Jan-07-2022)5,877Market Cap (Jan-07-2022)2.22 Billion USDAnnual Revenue in USD868 Million USDAnnual Net Income in USD159 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileHarmony Biosciences Holdings is a Pharmaceutical company. It focuses on disorders of sleep and wakefulness and currently working to advance the understanding of narcolepsy and provide information and resources to people who live with and healthcare professionals who treat, this chronic, debilitating neurologic disorder. The headquarters is in USA.
Facts About CompanyThe company annual revenue was 437 million USD and net income was 181 million USD as on 2022.
Company Website -
Biohaven Pharmaceutical Holding Company
World Rank (Aug-2026)6,000Market Cap (Aug-2026)2.211 Billion USDWorld Rank (Jan-05-2024)3,972Market Cap (Jan-05-2024)3.399 Billion USDWorld Rank (Jul-30-2023)7,470Market Cap (Jul-30-2023)1.300 Billion USDWorld Rank (Dec-25-2022)8,706Market Cap (Dec-25-2022)0.934 Billion USDWorld Rank (Jan-07-2022)2,147Market Cap (Jan-07-2022)8.44 Billion USDAnnual Revenue in USD463 Million USDAnnual Net Income in USD-847 Million USDAnnual Results for Period EndingFor year ending December-2021Company ProfileBiohaven Pharmaceutical Holding Company is a Clinical Stage Biopharmaceutical company. It portfolio is comprised of innovative, late stage product candidates targeting neurological and neuropsychiatric diseases including rare disorders. The company is rapidly progressing multiple compounds in clinical trials across three platforms they are calcitonin gene related peptide receptor antagonism, glutamate modulation and myeloperoxidase inhibition. The headquarters is in USA.
Company Website -
Ocular Therapeutix
World Rank (Aug-2026)6,015Market Cap (Aug-2026)2.205 Billion USDWorld Rank (Jan-05-2024)12,314Market Cap (Jan-05-2024)0.523 Billion USDWorld Rank (Jul-30-2023)14,969Market Cap (Jul-30-2023)0.350 Billion USDWorld Rank (Dec-25-2022)17,875Market Cap (Dec-25-2022)0.206 Billion USDWorld Rank (Jan-07-2022)13,549Market Cap (Jan-07-2022)0.49 Billion USDAnnual Revenue in USD52 Million USDAnnual Net Income in USD-266 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileOcular Therapeutix is a Biopharmaceutical Platform company focused on the formulation, development and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel based formulation technology. The company annual revenue is 12.3 million USD and 167 employees as on 2019. The headquarters is in USA.Company Website